Various other non-canonical TGF-β1 signal transducers, such as GSK-3β and NF-κB, also suppress the expression of Smad3 (canonical TGF-β1 signaling) in breast cancer [297,298,299]. This evidence concerns the gene SMAD3 and breast carcinoma.